Shopping Cart
Remove All
Your shopping cart is currently empty
Anticancer agent 195
😃Good
Catalog No. T209334
Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity.
Anticancer agent 195
Anticancer agent 195
😃Good
Catalog No. T209334
Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity. |
| In vitro | Anticancer agent 195 (10 μM) hinders the interaction between ELF3 and MED23, inhibits the activity of the HER2 promoter, and reduces AKT and MAPK phosphorylation. Additionally, in NCI-N87 cells, this agent exhibits antiproliferative effects and promotes apoptosis, effectively overcoming resistance to trastuzumab. |
| In vivo | The anticancer agent 195, administered at a dosage of 4 mg/kg through intravenous injection over a period of 25 days, inhibits tumor growth in athymic nude mice with NCI-N87 xenografts. |
| Formula | C24H28O6 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anticancer agent 195 | purchase Anticancer agent 195 | Anticancer agent 195 cost | order Anticancer agent 195 | Anticancer agent 195 in vivo | Anticancer agent 195 in vitro | Anticancer agent 195 formula
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.